JBI Evidence Synthesis · 6 Nov 2026
Causal inference with real-world data in health care research: a scoping review protocol and study within a review protocol
Stella Erdmannh-index 5, Leonard Levin, Meinhard Kieserh-index 14
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Objective: This study will improve the understanding and application of causal inference methods in health care research using real-world data (RWD). It seeks to systematically synthesize existing methods across different data sources, and assess whether large language models (LLMs) can support key steps in review processes. Introduction: Randomized controlled trials are considered the gold standard for evaluating treatment effects, as randomization balances confounders and enables causal inference. However, randomized controlled trials are often costly, time-consuming, or ethically infeasible. As a result, RWD, such as electronic health records, medical registries, and health insurance claims, are increasingly used in medical research. Complex methods are necessary to derive causal inference from RWD. Eligibility criteria: Studies that use RWD, evaluate any type of health outcome as a primary endpoint in order to investigate patient health status, address a causal question related to a treatment or intervention, and estimate a causal effect size related to the causal question will be eligible for inclusion. Methods: PubMed, Embase.com, and Web of Science will be searched for articles published in peer-reviewed journals between January 1, 2010, and January 29, 2026. A scoping review will be conducted to identify and categorize causal inference methods applied to RWD, focusing on theoretical frameworks, data requirements, and inferential assumptions in order to develop a taxonomy of methods. The frequency, context of use, and quality of reporting will be systematically assessed. In parallel, a study within a review (SWAR) will evaluate the performance of LLMs for title and abstract screening and full-text data extraction compared with human reviewers. Review registration: OSF https://osf.io/69mcd; SWAR Store (ID 66) https://www.qub.ac.uk/sites/TheNorthernIrelandNetworkforTrialsMethodologyResearch/FileStore/SWARFileStore/SWAR66%20Stella%20Erdmann%20(2025%20AUG%2001%202302).pdf
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Meinhard Kieser has the highest h-index among the authors (14).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (12)
What it cites, from open citation data, with Crossref's record of each.